These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 8780331)
1. Maintaining sinus rhythm with antifibrillatory drugs in atrial fibrillation. Antman EM Am J Cardiol; 1996 Aug; 78(4A):67-72. PubMed ID: 8780331 [TBL] [Abstract][Full Text] [Related]
2. Atrial fibrillation and flutter: maintaining stability of sinus rhythm versus ventricular rate control. Antman EM J Cardiovasc Electrophysiol; 1995 Oct; 6(10 Pt 2):962-71. PubMed ID: 8548117 [TBL] [Abstract][Full Text] [Related]
3. Risks and benefits of rate control versus maintenance of sinus rhythm. Saxonhouse SJ; Curtis AB Am J Cardiol; 2003 Mar; 91(6A):27D-32D. PubMed ID: 12670639 [TBL] [Abstract][Full Text] [Related]
4. Rate versus rhythm control in patients with atrial fibrillation: what the trials really say. Crijns HJ Drugs; 2005; 65(12):1651-67. PubMed ID: 16060699 [TBL] [Abstract][Full Text] [Related]
5. The medical management of atrial fibrillation. Masoudi FA; Goldschlager N Cardiol Clin; 1997 Nov; 15(4):689-719. PubMed ID: 9403169 [TBL] [Abstract][Full Text] [Related]
7. [In recurrent atrial fibrillation should a sinus rhythm always try to be maintained? No. What are the therapeutic alternatives?]. Bonhorst D Rev Port Cardiol; 1999 Oct; 18(10):909-14. PubMed ID: 10590655 [TBL] [Abstract][Full Text] [Related]
8. Randomized trials of rate vs. rhythm control for atrial fibrillation. Chung MK J Interv Card Electrophysiol; 2004; 10 Suppl 1():45-53. PubMed ID: 14739739 [TBL] [Abstract][Full Text] [Related]
9. [Cardioversion for atrial fibrillations: not better than ventricular rate control]. Verheugt FW Ned Tijdschr Geneeskd; 2003 Apr; 147(14):636-8. PubMed ID: 12712644 [TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation: pharmacological therapy. Patel C; Salahuddin M; Jones A; Patel A; Yan GX; Kowey PR Curr Probl Cardiol; 2011 Mar; 36(3):87-120. PubMed ID: 21392636 [TBL] [Abstract][Full Text] [Related]
11. Rhythm or rate control in atrial fibrillation: insights from the randomized controlled trials. Grönefeld G; Hohnloser SH J Cardiovasc Pharmacol Ther; 2003 Jun; 8 Suppl 1():S39-44. PubMed ID: 12746751 [TBL] [Abstract][Full Text] [Related]
15. A perspective on rate control in the treatment of atrial fibrillation. Waldo AL Clin Cardiol; 2004 Mar; 27(3):121-4. PubMed ID: 15049376 [TBL] [Abstract][Full Text] [Related]
16. Risk of complications of atrial fibrillation. Capucci A; Villani GQ; Aschieri D Pacing Clin Electrophysiol; 1997 Oct; 20(10 Pt 2):2684-91. PubMed ID: 9358515 [TBL] [Abstract][Full Text] [Related]
17. Rate control in atrial fibrillation: choice of treatment and assessment of efficacy. Boriani G; Biffi M; Diemberger I; Martignani C; Branzi A Drugs; 2003; 63(14):1489-509. PubMed ID: 12834366 [TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation and stroke: elucidating a newly discovered risk factor. Giardina EG Am J Cardiol; 1997 Aug; 80(4C):11D-18D; discussion 35D-39D. PubMed ID: 9284039 [TBL] [Abstract][Full Text] [Related]
20. Drug treatment of atrial fibrillation: what have we learned? Hohnloser SH; Li YG Curr Opin Cardiol; 1997 Jan; 12(1):24-32. PubMed ID: 9132077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]